BCL3 and colorectal cancer: Indeed, a recent study demonstrated that Bcl3-/- mice exhibit increased sensitivity to cisplatin chemotherapy in colorectal cancer, thus offering a rationale for targeting Bcl3 as an adjuvant to conventional therapies [216].